U.S. Patent No.
9,856,287 (Refolding Proteins Using a Chemically Controlled Redox State)
Patent Owner
Amgen Inc.; Amgen Manufacturing Ltd.
Petitioner(s)
Fresenius Kabi USA, LLC; Fresenius Kabi AG; Fresenius Kabi Deutschland GmbH; Fresenius Kabi Pharmaceuticals Holding, Inc.; Fresenius Kabi SwissBioSim GmbH; Fresenius SE & Co. KGaA; Dr. Reddy's Laboratories Inc.; Dr. Reddy's Laboratories, Ltd.; Dr. Reddy's Laboratories, SA
§ 102 Challenge
Y
Claim Types Challenged Under § 102
Manufacturing
§ 102 Challenge Instituted
N
§ 103 challenge
Y
Claim Types Challenged Under § 103
Manufacturing
§ 103 Challenge Instituted
N
IPR Status
IPR Not Instituted
U.S. Patent No.
9,856,287 (Refolding Proteins Using a Chemically Controlled Redox State)
Patent Owner
Amgen Inc.; Amgen Manufacturing Ltd.
Petitioner(s)
Fresenius Kabi USA, LLC; Fresenius Kabi AG; Fresenius Kabi Deutschland GmbH; Fresenius Kabi Pharmaceuticals Holding, Inc.; Fresenius Kabi SwissBioSim GmbH; Fresenius SE & Co. KGaA; Dr. Reddy's Laboratories Inc.; Dr. Reddy's Laboratories, Ltd.; Dr. Reddy's Laboratories, SA
§ 102 Challenge
Y
Claim Types Challenged Under § 102
Manufacturing
§ 102 Challenge Instituted
Settled Prior to Institution Decision
§ 103 challenge
Y
Claim Types Challenged Under § 103
Manufacturing
§ 103 Challenge Instituted
Settled Prior to Institution Decision
Settled / Challenged Claims Disclaimed / Challenge Terminated
Y (Settled Prior to Institution Decision)
IPR Status
Settled Prior to Institution Decision